2021-01-04,Aeglea BioTherapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
2020-12-30,Aeglea (AGLE) Upgraded to Buy: Here's Why
2020-12-18,Is AGLE A Good Stock To Buy Now According To Hedge Funds?
2020-12-17,Aeglea BioTherapeutics Appoints Alison Lawton to Board of Directors
2020-12-01,Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria
2020-11-24,Aeglea BioTherapeutics Announces New Presentation Time at Upcoming Investor Conference
2020-11-17,Aeglea BioTherapeutics to Participate in Two Upcoming Virtual Investor Conferences
2020-11-10,"How Much Are Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Insiders Spending On Buying Shares?"
2020-11-05,Aeglea BioTherapeutics Reports Third Quarter 2020 Financial Results and Corporate Highlights
2020-11-03,Is a Surprise Coming for Aeglea (AGLE) This Earnings Season?
2020-10-26,Aeglea BioTherapeutics Announces U.S. and EU Orphan Drug Designations for ACN00177 for the Treatment of Homocystinuria
2020-10-13,"Hedge Funds Are Crazy About Aeglea BioTherapeutics, Inc. (AGLE)"
2020-10-05,Aeglea BioTherapeutics Announces Presentations on Arginase 1 Deficiency and Homocystinuria Programs at Two Upcoming Virtual Medical Meetings
2020-09-11,Is Aeglea BioTherapeutics (NASDAQ:AGLE) In A Good Position To Invest In Growth?
2020-09-02,Aeglea BioTherapeutics to Participate in September Investment Conferences
2020-08-25,Aeglea (AGLE) Looks Good: Stock Adds 5.8% in Session
2020-08-18,Aeglea BioTherapeutics to Present at World Orphan Drug Congress USA 2020
2020-08-10,Aeglea BioTherapeutics Reports Second Quarter 2020 Financial Results and Corporate Highlights
2020-07-13,How Should Investors React To Aeglea BioTherapeutics' (NASDAQ:AGLE) CEO Pay?
2020-06-30,"Were Hedge Funds Right About Buying Aeglea BioTherapeutics, Inc. (AGLE)?"
2020-06-29,Here's Why Momentum Investors Will Love Aeglea Biotherapeutics (AGLE)
2020-06-26,Has Aeglea BioTherapeutics (AGLE) Outpaced Other Medical Stocks This Year?
2020-06-23,Aeglea BioTherapeutics (AGLE) Catches Eye: Stock Jumps 5.1%
2020-06-10,Has Aeglea BioTherapeutics (AGLE) Outpaced Other Medical Stocks This Year?
2020-06-08,Why Aeglea BioTherapeutics (AGLE) Stock Might be a Great Pick
2020-06-04,Zacks.com featured highlights include: Aeglea BioTherapeutics and Passage Bio
2020-06-01,Aeglea BioTherapeutics to Present at BIO Digital 2020
2020-05-29,"Aeglea BioTherapeutics' Shares March Higher, Can It Continue?"
2020-05-28,"Aeglea BioTherapeutics Announces Change of Location of Annual Meeting of Stockholders to Be Held June 8, 2020"
2020-05-27,Menlo Therapeutics (MNLO) Catches Eye: Stock Jumps 7.1%
2020-05-26,Aeglea BioTherapeutics Announces 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology
2020-05-21,Is Aeglea BioTherapeutics (AGLE) Outperforming Other Medical Stocks This Year?
2020-05-20,"Zacks.com featured highlights include: Aeglea BioTherapeutics, VeriSign, Sequans Communications and New Jersey Resources"
2020-05-19,Find Strong Stocks During the Coronavirus with New Analyst Coverage
2020-05-19,4 Stocks in the Limelight on New Analyst Coverage
2020-05-19,Aeglea BioTherapeutics to Present Late-Breaking 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology
2020-05-07,Is Aeglea BioTherapeutics (AGLE) Stock a Solid Choice Right Now?
2020-05-07,Aeglea BioTherapeutics Reports First Quarter 2020 Financial Results and Corporate Highlights
2020-05-06,"Aeglea BioTherapeutics, Inc. (AGLE) Shares March Higher, Can It Continue?"
2020-05-06,"Anthony Quinn Is The President of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) And They Just Picked Up 44% More Shares"
2020-05-05,Aeglea (AGLE) Upgraded to Strong Buy: What Does It Mean for the Stock?
2020-04-30,Aeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-04-28,Aeglea BioTherapeutics Announces Pricing of $120 Million Public Offering
2020-04-27,Aeglea BioTherapeutics Announces Proposed Public Offering
2020-04-08,Aeglea BioTherapeutics Announces Approval of Clinical Trial Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)
2020-03-29,"Does Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Have A Particularly Volatile Share Price?"
2020-02-24,"Aeglea BioTherapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, Highlights Recent Milestones"
2020-02-13,Should Aeglea BioTherapeutics (NASDAQ:AGLE) Be Disappointed With Their 66% Profit?
2020-01-13,Aeglea BioTherapeutics Submits CTA Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)
2020-01-08,"Is Aeglea BioTherapeutics, Inc.'s (NASDAQ:AGLE) CEO Salary Justified?"
2020-01-06,Aeglea BioTherapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference
2019-12-12,"Hedge Funds Are Dumping Aeglea BioTherapeutics, Inc. (AGLE)"
2019-12-03,"Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Insiders Increased Their Holdings"
2019-11-26,Aeglea BioTherapeutics to Participate in Upcoming Investor Conferences
2019-11-06,Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights
2019-11-04,Aeglea BioTherapeutics Strengthens Leadership Team with Appointment of Ravi M. Rao as Chief Medical Officer and Michael C. Hanley as Chief Commercial Officer
2019-10-10,Will Aeglea BioTherapeutics (NASDAQ:AGLE) Spend Its Cash Wisely?
2019-09-04,"Does Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Have A Volatile Share Price?"
2019-09-03,Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
2019-08-29,Aeglea BioTherapeutics to Present New 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 SSIEM Symposium
2019-08-06,Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
2019-07-25,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug"
2019-07-24,Aeglea BioTherapeutics Receives FDA Breakthrough Therapy Designation for Pegzilarginase for Treatment of Arginase 1 Deficiency
2019-07-17,"Can We See Significant Institutional Ownership On The Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Share Register?"
2019-06-14,"Aeglea Biotherapeutics Inc (AGLE) President & CEO Anthony G. Quinn Bought $196,535 of Shares"
2019-06-11,"Hedge Funds Have Never Been This Bullish On Aeglea BioTherapeutics, Inc. (AGLE)"
2019-06-03,Aeglea BioTherapeutics Doses First Patient in Pivotal Phase 3 PEACE Trial of Pegzilarginase in Arginase 1 Deficiency
2019-05-30,Aeglea BioTherapeutics to Participate in Upcoming Investor and Industry Conferences
2019-05-24,These 3 Biotech Stocks Are Attracting Insider Buying
2019-05-22,"Aeglea Biotherapeutics Inc (AGLE) President & CEO Anthony G. Quinn Bought $180,028 of Shares"
2019-05-07,Aeglea: 1Q Earnings Snapshot
2019-05-07,Aeglea BioTherapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights
2019-04-27,"Have Insiders Been Selling Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Shares?"
2019-04-08,Aeglea (AGLE) Reports New Positive Data for Pegzilarginase
2019-04-07,Aeglea BioTherapeutics Announces New Positive Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 Annual Meeting of the Society for Inherited Metabolic Disorders
2019-04-01,Aeglea BioTherapeutics to Present Updated Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency in an Oral Presentation at the 2019 Annual Meeting of the Society for Inherited Metabolic Disorders
2019-03-28,Aeglea BioTherapeutics to Participate in Upcoming Investor Conferences
2019-03-12,Edited Transcript of AGLE earnings conference call or presentation 7-Mar-19 9:30pm GMT
2019-03-08,Aeglea BioTherapeutics (AGLE) Q4 2018 Earnings Conference Call Transcript
2019-03-07,Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
2019-03-06,The Aeglea BioTherapeutics Share Price Is Up 11% And Shareholders Are Holding On
2019-02-28,Aeglea BioTherapeutics to Host Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights Conference Call
2019-02-07,Aeglea aims to raise $60M for treating rare diseases
2019-02-06,Aeglea BioTherapeutics Announces Pricing of $60.0 Million Public Offering
2019-02-05,Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
2019-01-29,"How Much Of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Do Institutions Own?"
2019-01-02,Austin's top-performing stocks of 2018
2018-12-23,"Is Aeglea BioTherapeutics, Inc. (AGLE) A Good Stock To Buy?"
2018-12-14,"What Investors Should Know About Aeglea BioTherapeutics, Inc.s (NASDAQ:AGLE) Financial Strength"
2018-12-11,Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency
2018-12-06,Aeglea BioTherapeutics to Present at BMO Capital Markets 2018 Prescription for Success Healthcare Conference
2018-11-20,Aeglea BioTherapeutics to Present at Evercore ISI HealthconX Conference
2018-11-14,"Report: Exploring Fundamental Drivers Behind Aeglea BioTherapeutics, Barnes & Noble Education, GSI Technology, Morgan Stanley, FTS International, and Crown Crafts  New Horizons, Emerging Trends, and Upcoming Developments"
2018-11-08,Aeglea: 3Q Earnings Snapshot
2018-11-08,Aeglea BioTherapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
2018-10-26,Aeglea BioTherapeutics to Present Preclinical Data on a New Pipeline Therapeutic for Cystinuria in an Oral Presentation at the 2018 American Society of Nephrology (ASN) Annual Meeting
2018-10-22,Aeglea BioTherapeutics Announces Positive Interim Clinical Data for Pegzilarginase in Advanced Melanoma Patients at the European Society for Medical Oncology 2018 Congress
2018-10-19,Aeglea BioTherapeutics to Present Preclinical Data on New Pipeline Therapeutic for Homocystinuria at 2018 American Society of Human Genetics (ASHG) Conference
2018-10-17,Aeglea BioTherapeutics Announces New Positive Interim Clinical Data and Improvements in Disease Manifestations for Ongoing Phase 1/2 Trial of Pegzilarginase in Patients with Arginase 1 Deficiency
2018-10-10,Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 ASHG Annual Meeting
